IPSC CENTURY THERAPEUTICS INC US FDA Inspections 8-K Filing 2023 - Other Special Situation Century Therapeutics announces that its Phase 1 clinical trial for CNTY-101 in patients with systemic lupus erythematosus can proceed.Get access to all SEC 8-K filings of the CENTURY THERAPEUTICS INC